Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Norris, James
One or more keywords matched the following items that are connected to
Norris, James
Item Type
Name
Academic Article
The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.
Academic Article
A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity.
Academic Article
Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.
Academic Article
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.
Academic Article
Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer.
Academic Article
Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer.
Academic Article
Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.
Academic Article
Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Academic Article
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
Academic Article
The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck.
Academic Article
Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.
Academic Article
Acid ceramidase inhibition: a novel target for cancer therapy.
Academic Article
Efficient growth suppression and apoptosis in human laryngeal carcinoma cell line HEP-2 induced by an adeno-associated virus expressing human FAS ligand.
Concept
Genetic Therapy
Search Criteria
Genetic Therapy